Prevalence and characteristics of malaria co-infection among individuals with visceral leishmaniasis in Africa and Asia: a systematic review and meta-analysis

Abstract

Background Malaria and visceral leishmaniasis (VL) co-infection can occur due to the overlapping geographical distributions of these diseases; however, only limited data of this co-infection have been reported and reviewed. This study aimed to explore the pooled prevalence and characteristics of this co-infection using a systematic review approach. Methods The PubMed, Web of Science and Scopus databases were searched for relevant studies. The quality of these studies was assessed in accordance with strengthening the reporting of observational studies in epidemiology (STROBE) guidelines. The numbers of individuals co-infected with Plasmodium and VL and the total numbers of individuals with VL were used to estimate the pooled prevalence using random-effects models. Differences in age, sex and the presence of anemia and malnutrition on admission were compared between co-infected individuals and individuals with VL using a random-effects model; the results are presented as odds ratios (ORs) and 95% confidence intervals (CIs). Heterogeneity among the included studies was assessed and quantified using Cochrane Q and I2 statistics. Results Of the 3075 studies identified, 12 met the eligibility criteria and were included in this systematic review. The pooled prevalence of Plasmodium infection among the 6453 individuals with VL was 13%, with substantial heterogeneity of the data (95% CI 7–18%, I2 97.9%). Subgroup analysis demonstrated that the highest prevalence of co-infection occurred in African countries, whereas the lowest prevalence occurred in Asian countries. Patients aged < 5 years had higher odds of having co-infection than having VL (co-infection, n = 202; VL, n = 410) (OR 1.66, 95% CI 1.37–2.01, I2 0%; P < 0.0001), whereas patients aged 20–29 years had lower odds of having co-infection than having VL (co-infection, n = 170; VL, n = 699) (OR 0.75, 95% CI 0.60–0.93, I2 18%; P = 0.01). Male patients had equivalent odds of having co-infection and having VL (co-infection, n = 525; VL, n = 2232) (OR 0.92, 95% CI 0.078–1.08, I2 0%; P = 0.29). Patients with co-infection had lower odds of having anemia at admission than those with VL (co-infection, n = 902; VL, n = 2939) (OR 0.64, 95% CI 0.44–0.93, I2 0%; P = 0.02). No difference in malnutrition at admission was found in the meta-analysis. Conclusions The prevalence of malaria co-infection among individuals with VL was heterogeneous and ranged from 7 to 18%, depending on geographical area. Age and anemia at admission were associated with co-infection status. Further longitudinal studies are needed to determine if co-infection with malaria has an impact on the severity of VL. Graphical abstract

Immunomodulatory Potential of Non-Classical HLA-G in Infections including COVID-19 and Parasitic Diseases

“…Furthermore, co-infections by several parasites are not uncommon. For example, those by Schistosoma haematobium and Plasmodium falciparum are frequent [ 96 , 97 , 98 , 99 ]. It has been shown that children with S. haematobium and P. falciparum coinfections exhibit lower expression levels of LILRB2, one of the receptors of HLA-G in B cells and neutrophils.…”

Procalcitonin as a Candidate Biomarker for Malarial Infection and Severe Malaria: A Meta-Analysis

“…Nevertheless, CRP was better than PCT at discriminating viral infections from bacterial infections [ 17 ]. PCT was more beneficial for critical care in the hospital context as it reacted faster to infections [ 10 , 35 , 36 ]. As PCT is also more rapidly eliminated, sharply decreasing PCT after treatment might be a marker for judging the curative effect of malaria as suggested by previous studies [ 36 , 39 , 40 ].…”

“…The misidentification of P. ovale as P. vivax or P. knowlesi as P. malariae is frequent and leads to underreported P. ovale and P. knowlesi cases [ 7 , 8 ]. In addition, other tropical diseases are reported in patients with malaria as a co-infection, making the clinical diagnosis difficult [ 9 , 10 , 11 , 12 , 13 , 14 ]. Moreover, the decision for the treatment of malaria relies on clinical assessment.…”

Malaria and leishmaniasis: Updates on co-infection

“…Another study conducted in 2014 in northwest Ethiopia, on the border with Sudan, showed that 4.2% of VL patients were co-infected with Plasmodium ( 13 ). Overall, a meta-analysis study with data from 1991 to 2020 suggests that the prevalence of Plasmodium co-infection among individuals with VL ranges from 7 to 18% in Africa and Asia, according to the endemicity of VL and malaria in the evaluated area ( 18 ).…”